Skip to content Skip to sidebar Skip to footer

What is Hepatitis C from a Medical Perspective?

What is Hepatitis C from a Medical Perspective?

Hepatitis C is a viral infection caused by the hepatitis C virus (HCV), an RNA virus primarily transmitted through blood-to-blood contact. It is a leading cause of chronic liver disease globally, with:

  • Acute Hepatitis C: 15-25% of cases resolve spontaneously within 6 months.
  • Chronic Hepatitis C: 75-85% progress to persistent infection, increasing risk of cirrhosis, liver cancer, and liver failure.
  • Genotypes: 6 major genotypes (1-6) with varying geographic prevalence and treatment responses.

Over 58 million people globally live with chronic HCV. It is a major cause of liver transplants and cancer-related deaths.

Symptoms of Hepatitis C

Acute Hepatitis C:

  • Often asymptomatic or mild flu-like symptoms.
  • Fatigue, nausea, abdominal pain, and dark urine.
  • Jaundice (yellowing of skin/eyes) in ~20% of cases.

Chronic Hepatitis C:

  • May remain asymptomatic for decades.
  • Advanced stages present with:
    • Ascites, variceal bleeding, and encephalopathy (cirrhosis).
    • Fatigue, itching, and spider angiomas.
    • Hepatocellular carcinoma (HCC) in 1-5% of cases over 20 years.

Hepatitis C Diagnostic Methods

Testing involves a two-step process:

  1. Screening Test:
    • Anti-HCV antibody test: Detects past/present infection.
  2. Confirmatory Test:
    • HCV RNA PCR test: Confirms active infection and quantifies viral load.
  3. Genotyping:
    • Determines genotype to guide treatment duration and drug selection.
  4. Liver Assessment:
    • Ultrasound, FibroScan, or biopsy to evaluate fibrosis/cirrhosis.

Medical Management of Hepatitis C

Acute Hepatitis C:

  • No routine antiviral therapy unless rapid progression occurs.
  • Monitor for spontaneous clearance (6-month HCV RNA test).

Chronic Hepatitis C:

  • Direct-Acting Antivirals (DAAs):
    • 95-99% cure rate with 8-12 week regimens (e.g., Sofosbuvir + Velpatasvir).
    • Genotype-specific regimens (e.g., genotype 3 may require longer treatment).
  • Liver Monitoring:
    • Biannual ultrasounds for HCC screening post-cure.

Frequently Asked Questions (FAQ)

Can Hepatitis C be cured?

Yes. Modern DAAs achieve cure (SVR12) in over 95% of cases. Treatment eliminates the virus permanently.

What is the window period for testing?

Antibodies appear 2-12 weeks post-infection. HCV RNA can be detected within 1-2 weeks. Confirmatory testing recommended 6 months post-exposure.

Is Hepatitis C transmitted through sex?

Low risk in monogamous relationships. Higher risk in HIV-positive individuals, those with multiple partners, or during anal sex. Condom use advised.

Can HCV recur after cure?

No. A sustained virologic response (SVR) means complete cure. However, re-infection is possible through re-exposure to HCV.

Does HCV affect life expectancy?

Untreated chronic HCV reduces life expectancy by 10-15 years. Early DAA treatment restores normal life expectancy.

Preventing Hepatitis C Transmission

  • Avoid Blood Contact:
    • Never share needles, razors, or toothbrushes.
    • Use sterile equipment for tattoos/piercings.
  • Blood Safety:
    • Ensure all blood donations are HCV-screened.
  • Needle Exchange Programs:
    • Reduce transmission among people who inject drugs.
  • Universal Precautions:
    • Healthcare workers must follow strict infection control protocols.

 

Leave a comment

Office

Room 725, William James Hall
Harvard University
33 Kirkland Street, Cambridge, MA 02138

Newsletter
© 2025. All Rights Reserved.Faculty of Sexual and Reproductive Healthcare
Our site uses cookies. Learn more about our use of cookies: cookie policy